NetworkNewsBreaks

TuesdayApr 21, 2020 11:43 am

NetworkNewsBreaks – Co-Diagnostics, Inc. (NASDAQ: CODX) Announces Continued Increase of COVID-19 Test Orders in the US

Co-Diagnostics (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, on Monday announced continued increase of its COVID-19 test sales in the United States as the federal government shifts responsibility to individual states to confront the need to double the amount of testing for the disease. Per the update, the Company received FDA Emergency Use Authorization on April 3, 2020, and has shipped tests to more than a dozen states throughout the country, in addition to receiving orders from nearly 50 countries worldwide. "It has been widely reported that the most…

Continue Reading

TuesdayApr 21, 2020 11:19 am

NetworkNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) Licensed to Sell All Lines of Insurance in 47 US States, Including California and Florida

InsuraGuest Technologies (TSX.V: ISGI) today announced that its wholly owned U.S. subsidiary, InsuraGuest Insurance Agency, LLC (the “Agency”), is now licensed to sell all lines of insurance in 47 out of the 50 U.S. states and Washington, D.C. According to the update, the Agency is registered and licensed to sell accident and health, casualty, life and property insurance in the District of Columbia and all states with exception to Massachusetts, New York and Washington, where it has submitted application and expects to be approved to sell insurance within the next 30 days in these three remaining states. “As the world…

Continue Reading

TuesdayApr 21, 2020 11:18 am

NetworkNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Initiates Program to Treat Patients with Pulmonary Complications from COVID-19 Infection with TNF Inhibitor “DN-TNF” Platform

INmune Bio (NASDAQ: INMB), an immunology company developing treatments that harness the patient’s innate immune system to fight disease, on Monday announced the initiation of a therapeutic program to treat patients with pulmonary complications from COVID-19 infection with its dominant-negative TNF inhibitor (“DN-TNF”) platform. According to the update, the program targets patients admitted to the hospital with hypoxia who do not yet require intensive respiratory support. If successful, DN-TNF treatment should decrease the need to transfer patients to the ICU and the need for mechanical ventilation. “In response to reports highlighting the role of TNF in the cytokine storm of…

Continue Reading

TuesdayApr 21, 2020 10:53 am

NetworkNewsBreaks – OriginClear, Inc. (OCLN) Relocates Corporate Headquarters to Combine with its Texas-Based Manufacturing Site

OriginClear (OTCQB: OCLN), a leading provider of water treatment solutions, today announced that it has relocated its corporate headquarters from Los Angeles to combine with its manufacturing site in McKinney, near Dallas, Texas. “We have enjoyed our stay at the La Kretz Campus of the Los Angeles Cleantech Incubator complex, including its extraordinary prototyping resources and its dedicated team,” OriginClear CEO Riggs Eckelberry said in the news release. “But increasingly, our California team has been virtual, and both development and manufacturing have been centered on our Texas location. This move reflects that fact.” To view the full press release, visit…

Continue Reading

TuesdayApr 21, 2020 10:43 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Appoints Accomplished Executive Shannon Inman to Drive Launch of Key Clinical Trials

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of Shannon Inman as Vice President of Global Clinical Operations. According to the update, Inman will lead in defining clinical developmental strategies, clinical protocol design, study conduct, and managing risk assessment in this new position. These clinical trials include those with Genprex’s lead drug candidate, Oncoprex(TM), for non-small cell lung cancer (“NSCLC”), which recently received Fast Track Designation for its combination with osimertinib, AstraZeneca’s first-line targeted EGFR TKI drug Tagrisso(R). “Genprex continues to strengthen its leadership team with…

Continue Reading

TuesdayApr 21, 2020 10:20 am

NetworkNewsBreaks – Cannabis Global, Inc. (MCTC) Announces New Line of Cannabinoid Beverage Infusion Technologies and Industry’s First THC-V Tea and Coffee Products

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced a new line of cannabinoid beverage infusion technologies and the industry's first Tetrahydrocannabivarin (“THC-V”) tea and coffee products. According to the update, the Company plans to begin marketing both the infusion technologies and the tea and coffee products beginning May 1, 2020. "We have completed our product development into combining THC-V and other rare cannabinoids into infusion substrates, which can then be easily added to virtually any beverage or into many foods,” Cannabis Global CEO Arman Tabatabaei said in the news…

Continue Reading

TuesdayApr 21, 2020 10:15 am

NetworkNewsBreaks – Youngevity International, Inc. (NASDAQ: YGYI) Subsidiaries Enter Joint Venture for Large Scale Processing Facility, 2,200 Acres to Grow Hemp in Nicaragua

Youngevity International (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise, commercial hemp enterprise and multi-channel lifestyle company, today announced that its wholly-owned subsidiaries, CLR Roasters LLC and Khrysos Industries, Inc. (the "US Partners") have entered into an agreement with H&H Coffee Group Export Corp and The Nica Hemp Cooperative, Inc (the "Nicaragua Partners") to acquire the 2,200 acre Chaguitillo Farms in Sebaco-Matagalpa, Nicaragua. The joint venture will utilize the property to erect a large-scale processing facility and to grow hemp on the land. Planned improvements to the property are anticipated to…

Continue Reading

TuesdayApr 21, 2020 9:46 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Files New Patent Application for DehydraTECH Technology in Delivery of Antiviral Drugs

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that it has filed an important new patent application in the United States describing the use of its DehydraTECH(TM) technology for the delivery of antiviral drugs. According to the update, the technology would potentially be used to improve treatment options for viral infectious diseases including COVID-19, MERS, SARS, influenza, herpes, hepatitis and AIDS. "Lexaria's proprietary drug delivery platform has already proven its effectiveness in the oral delivery of other lipophilic drugs such as nicotine, cannabinoids, and more, with multi-fold increases in both the rate…

Continue Reading

MondayApr 20, 2020 12:55 pm

NetworkNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) and D2D Announce Successful Launch of Virtual Live Auctions in the US

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), together with its partner D2D Auto Auction LLC, today announced the successful launch and completion of "virtual" auctions in the United States. According to the update, the two virtual auctions, held on April 7 and 16, were highly successful and proved the speed and efficiency of D2D's unique transaction platform, an alternative to physical auctions and associated costs. Using the D2D platform, dealers and consumers benefit with elimination of the cost of delivering a vehicle to a physical auction and payment of a minimal transaction fee only after a car is successfully…

Continue Reading

MondayApr 20, 2020 12:26 pm

NetworkNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) to Present at the SNN Planet MicroCap Showcase Virtual Investor Conference

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the Additive Manufacturing industry, today announced that management will attend the SNN Planet MicroCap Showcase Virtual Investor Conference on Wednesday, April 22, 2020. According to the update, Sigma Labs Executive Chairman Mark K. Ruport will present an overview of the business model and growth initiatives. The presentation, scheduled to begin at 8:00 p.m. Eastern Time (5:00 p.m. Pacific Time) on April 22, will be followed by a question and answer session. To register for the presentation, visit http://nnw.fm/58aHW To view the full press release, visit http://nnw.fm/GI8Rm About Sigma…

Continue Reading